KCNQ1 and type 2 diabetes mellitus: Inhibition of the KCNQ1 gene in pancreatic beta cells can increase insulin secretion and insulin granules exocytosis, whereas overexpression decreases insulin exocytosis and secretion, thereby enhancing T2DM susceptibility (6, 7).